In a rapidly evolving biopharmaceutical landscape, Quotient Sciences stands out for its relentless drive toward innovation in personalized medicine. Spearheaded by CEO Thierry Van Nieuwenhove, the company has made significant strides, particularly in the areas of pediatric therapies and emerging
Can ProBiotix and Eifron's Partnership Revolutionize Cardiometabolic Health? ProBiotix Health Plc has recently announced a significant commercial partnership with Greek consumer brand specialist Eifron SA, a collaboration poised to make substantial strides in the domain of cardiometabolic
The global Pharmaceutical Cleaning Validation market is experiencing significant growth, projected to reach an impressive USD 28.40 billion by 2030. With a compound annual growth rate (CAGR) of 6.7% from 2024 to 2030, this market expansion underscores the critical importance of ensuring drug safety
The pharmaceutical packaging industry is on the cusp of significant changes as we move into 2024 and beyond, driven by innovations designed to enhance patient experience, ensure safety, and comply with evolving regulatory requirements. Dexter Tjoa, the CEO of Tjoapack, sheds light on the major
Theratechnologies, a Montreal-based pharmaceutical company, is grappling with an unexpected supply disruption of its HIV medication Egrifta SV. This drug, which serves to reduce excess abdominal fat in HIV patients with lipodystrophy, has encountered a significant hurdle stemming from the
In an unprecedented move set to revolutionize emergency cardiac care, Asamedic and Bormioli Pharma have formed a groundbreaking partnership to commercialize Coxor, a 300mg Acetylsalicylic acid medication designed for the urgent treatment of suspected acute myocardial infarction. Unlike traditional
